[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-567376-105":53,"doc-detail-567376-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","antibiotic-sensitivity-chart-june-2026","Antibiotic Sensitivity Chart - June 2026","","Antibiotic Sensitivity Chart (June 2026) organizes antibacterial options by bacterial groups and relevant sites of infection, distinguishing Gram-positive cocci, Gram-negative bacilli/coccobacilli, anaerobes, and atypical pathogens. It maps multiple antibiotic classes—including penicillins, cephalosporins, monobactams, carbapenems, macrolides, tetracyclines, and fluoroquinolones—to specific organisms. The chart includes notes on resistance patterns and restrictions (e.g., avoid or only in combination scenarios), supporting targeted selection for clinical use.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/antibiotic-sensitivity-chart-june-2026/567376/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/antibiotic-sensitivity-chart-june-2026/567376.png","ImageObject",442,249,{"name":88,"@type":89},"Cart","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-22","2026-10-13",true,{"@type":98,"interactionType":99,"userInteractionCount":47},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"How is the antibiotic information organized in the chart?","Question",{"text":108,"@type":109},"The chart groups bacteria by major categories (e.g., Gram-positive cocci, Gram-negative bacilli/coccobacilli, anaerobes, atypicals) and aligns antibiotic options and sites of infection for each group.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"Which antibiotic classes are included?",{"text":113,"@type":109},"Included classes cover penicillins, cephalosporins, monobactams, carbapenems, macrolides, tetracyclines, and fluoroquinolones, with organism-specific examples listed.",{"name":115,"@type":106,"acceptedAnswer":116},"Does the chart indicate situations to avoid or use antibiotics in combination?",{"text":117,"@type":109},"Yes. The chart contains explicit cautions such as “Avoid in serious infections” and statements like “Only in Combination” for certain drug options.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},567376,1792090568,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":47,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":9,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":4},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","| ANTIBIOTIC SENSITIVITY CHART |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Created by James McCormack, PharmD and Fawziah Lalji, BSc(Pharm), PharmD with assistance from Drs. Cesilia Nishi, Solomon Chow, Tim Lau Faculty of Pharmaceutical Sciences, University of British Columbia, and Vancouver Hospital, Vancouver, BC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| Bacteria | Gram Positive Cocci |  |  |  |  |  | Gram Negative Bacilli |  |  |  |  |  | Gram Negative Coccobacilli |  | Anaerobes |  |  | Atypicals |  |  |\n|  | Streptococci |  | Staphylococci |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n|  | Streptococcus\u003Cbr>(pneumoniae /\u003Cbr>pyogenes /\u003Cbr>viridans group) | Enterococcus faecalis | Staphylococcus\u003Cbr>epidermidis\u003Cbr>(coagulase negative) | Staphylococcus\u003Cbr>aureus\u003Cbr>(Methicillin sensitive, MSSA) | Community\u003Cbr>acquired\u003Cbr>(Methicillin\u003Cbr>resistant\u003Cbr>S.aureus,\u003Cbr>cMRSA) | Hospital\u003Cbr>acquired\u003Cbr>(Methicillin\u003Cbr>resistant\u003Cbr>S.aureus,\u003Cbr>MRSA) | Non-beta-lactamase producing\u003Cbr>Escherichia coli ,\u003Cbr>Klebsiella pneumoniae/oxytoca ,\u003Cbr>Haemophilus influenzae | Beta-lactamase\u003Cbr>producing\u003Cbr>Escherichia coli,\u003Cbr>Klebsiella\u003Cbr>pneumoniae/oxytoca,\u003Cbr>Haemophilus influenzae | AmpC producing\u003Cbr>(HECK YeS)\u003Cbr>Hafnia alvei ,\u003Cbr>Enterobacter cloacae ,\u003Cbr>Citrobacter freundii,\u003Cbr>Klebsiella aerogenes, Yersinia\u003Cbr>enterocolitica | ESBL-E\u003Cbr>(Extended spectrum beta\u003Cbr>lactamase producing)\u003Cbr>Enterobacterales | CRE\u003Cbr>(Carbapenem-resistant\u003Cbr>Enterobacterales ) | Pseudomonas\u003Cbr>aeruginosa | Neisseria\u003Cbr>meningitidis | Neisseria\u003Cbr>gonorrhoeae | Above the diaphragm\u003Cbr>(Peptostreptococcus ) | Below the\u003Cbr>diaphragm\u003Cbr>(Bacteroide s spp) | Clostridioides\u003Cbr>difficile | Mycoplasma\u003Cbr>pneumoniae,\u003Cbr>Chlamydophilaspp | Legionella\u003Cbr>pneumophila | Chlamydia\u003Cbr>trachomatis |\n| Site of infection | CNS, oral, respiratory tract,\u003Cbr>heart, skin | Intraabdominal,\u003Cbr>urinary tract | Skin, prosthetics | Respiratory tract, heart, skin, bones/joint |  |  | Respiratory, intraabdominal, urinary tract, and others |  |  |  |  |  | Central nervous\u003Cbr>system | Pelvic\u003Cbr>inflammatory\u003Cbr>disease/STI | Oral, respiratory tract | Intraabdominal,\u003Cbr>pelvic inflammatory\u003Cbr>disease | Intraabdominal | Respiratory tract |  | Pelvic inflammatory\u003Cbr>disease/STI |\n| Penicillins | Pencillin V/G |  |  |  |  |  |  |  |  |  |  |  | Pencillin G-IV |  | Pencillin V/G |  |  |  |  |  |\n|  | Amoxicillin/Ampicillin |  |  |  |  |  | Amoxicillin/Ampicillin |  |  |  |  |  | Ampicillin-IV |  | Amoxicillin/Ampicillin |  |  |  |  |  |\n|  |  |  |  | Cloxacillin |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n|  | Amoxicillin-clavulanate |  |  | Amoxicillin-clavulanate |  |  | Amoxicillin-clavulanate |  | Avoid in serious infections |  |  |  |  |  | Amoxicillin-clavulanate |  |  |  |  |  |\n|  | Piperacillin-tazobactam |  |  | Piperacillin-tazobactam |  |  | Piperacillin-tazobactam |  | Avoid in serious infections |  |  | Piperacillintazobactam |  |  | Piperacillin-tazobactam |  |  |  |  |  |\n| Cephalosporins | Cefazolin/Cephalexin |  |  | Cefazolin/Cephalexin |  |  | Cefazolin/Cephalexin |  |  |  |  |  |  |  | Cefazolin/Cephalexin |  |  |  |  |  |\n|  | Cefuroxime |  |  | Cefuroxime |  |  | Cefuroxime |  |  |  |  |  |  |  | Cefuroxime |  |  |  |  |  |\n|  | Cefoxitin |  |  | Cefoxitin |  |  | Cefoxitin |  |  |  |  |  |  |  | Cefoxitin |  |  |  |  |  |\n|  | Ceftriaxone/Cefotaxime |  |  | Ceftriaxone/Cefotaxime |  |  | Ceftriaxone/Cefotaxime |  |  |  |  |  | Ceftriaxone/Cefotaxime |  |  |  |  |  |  |  |\n|  | Cefixime |  |  |  |  |  | Cefixime |  |  |  |  |  |  | Cefixime |  |  |  |  |  |  |\n|  |  |  |  |  |  |  | Ceftazidime |  |  |  |  | Ceftazidime |  |  |  |  |  |  |  |  |\n|  | Cefipime |  |  | Cefipime |  |  | Cefipime |  | Unpredictable activity |  |  | Cefipime |  |  | Cefipime |  |  |  |  |  |\n|  |  |  |  |  |  |  | C","cbCaitmwvoQ3TZdx","https://ap.wps.com/l/cbCaitmwvoQ3TZdx","pdf",302134,"English","# Antibiotic sensitivity by pathogen group\n## Antibiotic classes and examples","[{\"question\":\"How is the antibiotic information organized in the chart?\",\"answer\":\"The chart groups bacteria by major categories (e.g., Gram-positive cocci, Gram-negative bacilli/coccobacilli, anaerobes, atypicals) and aligns antibiotic options and sites of infection for each group.\"},{\"question\":\"Which antibiotic classes are included?\",\"answer\":\"Included classes cover penicillins, cephalosporins, monobactams, carbapenems, macrolides, tetracyclines, and fluoroquinolones, with organism-specific examples listed.\"},{\"question\":\"Does the chart indicate situations to avoid or use antibiotics in combination?\",\"answer\":\"Yes. The chart contains explicit cautions such as “Avoid in serious infections” and statements like “Only in Combination” for certain drug options.\"}]","Antibiotic Sensitivity Chart - June 2026 | PDF",1791866154]